¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"eosinophilic granulocyte"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
¿µ¹® granulocyte ÇÑ±Û °ú¸³±¸
¼³¸í   
  °ú¸³±¸¶õ ÀûÇ÷±¸¸¦ Á¦¿ÜÇÑ Ç÷¾×¼ÓÀÇ ¼¼Æ÷ÀΠ¹éÇ÷±¸ÀÇ 60%¸¦ Â÷ÁöÇϸç, ¼¼Æ÷¼Ó¿¡ Æ¯ÀÌÇÑ °ú¸³À» °¡Áö°í Àִ ¼¼Æ÷À̸ç, ´ÙÀ½°ú °°Àº 3°¡ÁöÀÇ ¼¼Æ÷°¡ À̰÷¿¡ Æ÷ÇÔÀÌ µÈ´Ù.
  
  1. È£¿°±â±¸(basophil)-¿°±â¼º ¿°»ö¾à¿¡ Àß ¿°»öÀÌ µÇ´Â °ú¸³À» °¡Áö°í ÀÖ´Ù. ºÒ±ÔÄ¢ÇÑ ¸ð¾çÀÇ ¼¼Æ÷·Î Çª¸¥»öÀ» ¶ì´Â °ú¸³ÀÌ ³Ê¹« ¸¹ÀÌ À־ ÇÙÀÌ Àß º¸ÀÌÁö ¾Ê´Â´Ù.
  
  2. È£»ê±¸(eosinophil)-»ê¼º ¿°»ö¾à¿¡ Àß ¿°»öÀÌ µÇ´Â °ú¸³À» °¡Áö°í ÀÖ°í, ´ë°³ ±â»ýÃæÀÇ °¨¿°À̳ª, ¾Ë·¹¸£±â¿¡¼­ ¸¹ÀÌ Áõ°¡¸¦ ÇÑ´Ù. ´ë°³ 2°³ÀÇ ÇÙÀ» °¡Áö°í ÀÖÀ¸¸ç ÇÙ»çÀÌ¿¡ °¡´Â ½Ç°°Àº °ÍÀ¸·Î À̾îÁ® ÀÖ´Ù.
  
  3. È£Áß±¸(neutrophil)-»ê¼º ¿°»ö¾àÀ̳ª ¿°±â¼º ¿°»ö¾àÀ̳ª ¸ðµÎ Àß µÇ´Â °ú¸³À» °¡Áö´Â ¼¼Æ÷·Î ´ë°³ 3°³ÀÇ ÇÙÀ» °¡Áø´Ù. ±×¸®°í ÇÙ »çÀÌ¿¡ °¡´Â ½Ç°°Àº ±¸Á¶¹°ÀÌ À־ ÇÙÀ» ¼­·Î À̾îÁÖ°í ÀÖ´Ù.
  
  ÀÌ °ú¸³±¸´Â ÁַΠ¸é¿ª¿¡ °ü°èµÈ ¿ªÇÒÀ» Çϴ °ÍÀ¸·Î ¾Ë·ÁÁ® ÀÖ´Ù. 
¿µ¹® segmented granulocyte ÇÑ±Û ºÐÀý °ú¸³±¸
¼³¸í   
  °ú¸³±¸(¼¼Æ÷Áú³»¿¡ Á¡°°Àº °ú¸³À» Æ÷ÇÔÇϴ ¼¼Æ÷)Áß ¸»ÃÊ Ç÷¾×À» ¼øÈ¯Çϴ ¼º¼÷µÈ °ú¸³±¸·Î ÇÙÀÇ ¸ð¾çÀÌ µÎ °³ ÀÌ»óÀÇ ºÐÀýÀ» ÀÌ·ç°í ÀÖ´Ù. ¿©±â¿¡´Â ±× ¿°»ö»óÀÇ ¹æ¹ý¿¡ µû¶ó È£Áß±¸(Áß¼º¿¡¼­ °ú¸³¿°»öÀ» º¸ÀÓ), È£»ê±¸(»ê¼º¿¡¼­ °ú¸³¿°»öÀ» º¸ÀÓ), È£¿°±¸(¿°±â¼º¿¡¼­ °ú¸³¿°»öÀ» º¸ÀÓ)·Î ³ª´¶´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • basophilic granulocyte
    È£¿°±â°ú¸³¹éÇ÷±¸, È£¿°±â°ú¸³±¸
  • granulocyte
    °ú¸³¹éÇ÷±¸, °ú¸³±¸
  • granulocyte colony-stimulating factor
    °ú¸³±¸Áý¶ôÀÚ±ØÀÎÀÚ
  • granulocyte-erythrocyte antigen
    °ú¸³±¸ÀûÇ÷±¸Ç׿ø
  • granulocyte-macrophage colony-stimulating factor
    °ú¸³±¸Å«Æ÷½Ä¼¼Æ÷Áý¶ôÀÚ±ØÀÎÀÚ, °ú¸³±¸´ë½Ä±¸Áý¶ôÀÚ±ØÀÎÀÚ
  • granulocyte-monocyte antigen
    °ú¸³±¸´ÜÇÙ±¸Ç׿ø
  • granulocyte-specific antigen
    °ú¸³±¸Æ¯ÀÌÇ׿ø
  • eosinophilic
    1. È£»ê- 2. È£»ê±¸- 3. È£»ê±¸Áõ°¡Áõ-
  • eosinophilic cell
    È£»ê¼¼Æ÷
  • eosinophilic cellulitis
    È£»ê±¸¿¬Á¶Á÷¿°
  • eosinophilic granuloma
    È£»ê±¸À°¾ÆÁ¾
  • eosinophilic leukemia
    È£»ê±¸¹éÇ÷º´
  • eosinophilic leukemoid reaction
    È£»ê±¸¹éÇ÷º´¸ð¾ç¹ÝÀÀ
  • eosinophilic meningoencephalitis
    È£»ê±¸¼ö¸·³ú¿°
  • eosinophilic myelocyte
    È£»ê°ñ¼ö¼¼Æ÷
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • eosinophilic
    È£»ê¼º-, È£»ê±¸-, È£»ê±¸Áõ°¡Áõ-
  • granulocyte
    °ú¸³¹éÇ÷±¸
  • basophilic granulocyte
    È£¿°±â°ú¸³¹éÇ÷±¸
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • granulocyte-erythrocyte antigen
    °ú¸³±¸ÀûÇ÷±¸Ç׿ø
  • granulocyte-monocyte antigen
    °ú¸³±¸´ÜÇÙ±¸Ç׿ø
  • granulocyte-specific antigen
    °ú¸³±¸Æ¯ÀÌÇ׿ø
  • granulocyte colony-stimulating factor
    °ú¸³±¸Áý¶ôÀÚ±ØÀÎÀÚ
  • granulocyte-macrophage colony-stimulating factor
    °ú¸³±¸Å«Æ÷½Ä¼¼Æ÷Áý¶ôÀÚ±ØÀÎÀÚ
  • granulocyte
    °ú¸³¹éÇ÷±¸
  • eosinophilic cell
    È£»ê¼¼Æ÷
  • eosinophilic cellulitis
    È£»ê±¸¿¬Á¶Á÷¿°
  • eosinophilic
    È£»ê¼º-, È£»ê±¸-, È£»ê±¸Áõ°¡Áõ-
  • eosinophilic granuloma
    È£»ê±¸À°¾ÆÁ¾
  • eosinophilic meningoencephalitis
    È£»ê±¸¼ö¸·³ú¿°
  • eosinophilic myelocyte
    È£»ê¼º°ñ¼ö¼¼Æ÷
  • eosinophilic process
    È£»ê¼ºµ¹±â
  • eosinophilic spongiosis
    È£»ê±¸Áõ°¡ÇظéÈ­
  • eosinophilic leukemoid reaction
    È£»ê±¸¹éÇ÷º´¸ð¾ç¹ÝÀÀ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Loeffler s eosinophilic syndrome
    ·ÚÇ÷¯È£»ê±¸ÁõÈıº
  • Loeffler s eosinophilic syndrome
    ·ÚÇ÷¯È£»ê±¸ÁõÈıº.
  • gastritis,eosinophilic
    È£»ê±¸¼º À§¿°
  • G-CSF (Granulocyte colony-stimulating factor)
    °ú¸³¼¼Æ÷±ºÃËÁøÀÎÀÚ(Î¨Ø£á¬øàÏØõµòäì×í­)
  • granulocyte
    °ú¸³¹éÇ÷__¡­ÛÜúìϹ), °ú¸³__
  • granulocyte
    °ú¸³±¸
  • granulocyte colony-stimulating factor
    °ú¸³±¸Áý¶ôÀÚ±ØÀÎÀÚ
  • granulocyte colony-stimulating factor=G-CSF
    °ú¸³±¸Áý¶ôÀÚ±ØÀÎÀÚ
  • granulocyte source
    °ú¸³±¸¿øÃµ<--±Ù¿ø
  • granulocyte transfusion
    °ú¸³¼¼Æ÷ ¼öÇ÷
  • granulocyte-erythrocyte antigens
    °ú¸³±¸ÀûÇ÷±¸Ç׿ø
  • granulocyte-macrophage coloneystimulating factor(gm-csf)
    °ú¸³±¸-´ë½Ä±¸ Áý¶ô ÀÚ±ØÀÎÀÚ
  • granulocyte-macrophage colony- stimulating factor
    °ú¸³±¸´ë½Ä¼¼Æ÷Áý¶ôÀÚ±ØÀÎÀÚ
  • granulocyte-macrophage colony-stimulating factor=GM-CSF
    °ú¸³±¸-´ë½Ä¼¼Æ÷Áý¶ôÀÚ±ØÀÎÀÚ
  • granulocyte-monocyte antigens
    °ú¸³±¸´Ü±¸Ç׿ø
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • eosinophilic granulocyte
    È£»ê¼º °ú¸³±¸
  • eosinophilic granulocyte
    È£»ê±¸¼º °ú¸³±¸
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • basophilic granulocyte
    È£¿°±â¼º °ú¸³¹éÇ÷±¸
  • basophilic granulocyte
    È£¿°¼º(û¿ç¤àõ) °ú¸³±¸(ΨأϹ)
  • circulating granulocyte pool
    ¼øÈ¯ °ú¸³¹éÇ÷±¸ Ǫ¿ï
  • granulocyte
    °ú¸³±¸
  • granulocyte
    °ú¸³¹éÇ÷__¡­ÛÜúìϹ), °ú¸³__
  • granulocyte colony-stimulating factor
    °ú¸³±¸Áý¶ôÀÚ±ØÀÎÀÚ
  • granulocyte colony-stimulating factor=G-CSF
    °ú¸³±¸Áý¶ôÀÚ±ØÀÎÀÚ
  • granulocyte source
    °ú¸³±¸¿øÃµ<--±Ù¿ø
  • granulocyte transfusion
    °ú¸³¼¼Æ÷ ¼öÇ÷
  • granulocyte-erythrocyte antigens
    °ú¸³±¸ÀûÇ÷±¸Ç׿ø
  • granulocyte-macrophage coloneystimulating factor(gm-csf)
    °ú¸³±¸-´ë½Ä±¸ Áý¶ô ÀÚ±ØÀÎÀÚ
  • granulocyte-macrophage colony- stimulating factor
    °ú¸³±¸´ë½Ä¼¼Æ÷Áý¶ôÀÚ±ØÀÎÀÚ
  • granulocyte-macrophage colony-stimulating factor=GM-CSF
    °ú¸³±¸-´ë½Ä¼¼Æ÷Áý¶ôÀÚ±ØÀÎÀÚ
  • granulocyte-monocyte antigens
    °ú¸³±¸´Ü±¸Ç׿ø
  • granulocyte-monocyte-lymphocyte antigens
    °ú¸³±¸´Ü±¸¸²ÇÁ±¸Ç׿ø
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Eosinophilic granule
    È£»ê¼º°ú¸³
    [¿¾ ¿ë¾î] »êÈ£¼º°ú¸³
  • Eosinophilic leukocyte
    È£»ê¼º¹éÇ÷±¸
    [¿¾ ¿ë¾î] »êÈ£¼º¹éÇ÷±¸
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • eosinophilic granuloma
    È£»ê±¸À°¾ÆÁ¾
  • eosinophilic meningoencephalitis
    È£»ê±¸¼ö¸·³ú¿°
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • eosinophilic granuloma
    È£»ê±¸¼ºÀ°¾ÆÁ¾
  • eosinophilic inclusion body
    È£»ê¼ººÀÀÔü
  • eosinophilic pneumonia
    È£»ê±¸¼ºÆó·Å
  • Loeffler's eosinophilic syndrome
    ·ÚÇ÷¯È£»ê±¸ÁõÈıº
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
MGP marginal granulocyte pool; marginating granulocyte pool; membranous glomerulonephropathy; mucin glyc...
ECF   1) Eosinophilic Chemotatic Factors
  2) Extra-Cellular Fluid; ¼¼Æ÷ ¿Ü¾×
BENAR blood eosinophilic non-allergic rhinitis
CEP chronic eosinophilic pneumonia; chronic erythropoietic porphyria; congenital erythropoietic porphyri...
ECF effective capillary flow; eosinophilic chemotactic factor; erythroid colony formation; extended care...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
GM-CSF Granulocyte colony-stimulating factor , granulocyte-macrophage colony-stimulating factor
G-CSF Granulocyte-Macrophage Colony-Stimulating Factor , Granulocyte Colony-Stimulating Factor
AEP Acute eosinophilic pneumonia
CEP Chronic eosinophilic pneumonia
ECP Eosinophilic Cationic Protein
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • eosinophilic cell
    È£»ê±¸
  • eosinophilic cephalitis
    È£»ê¼º ô¼ö ³ú¿°
  • eosinophilic coagulum
    È£»ê¼º ÀÀ±«, È£»ê¼º ÀÀ±«
  • eosinophilic fasciitis
    È£»ê±¸¼º ±Ù¸·¿°
  • eosinophilic granule
    È£»ê¼º °ú¸³
  • eosinophilic granuloma
    È£»ê±¸¼º À°¾ÆÁ¾, È£»ê¼º À°¾ÆÁ¾
    1. ´Ù¼Ò¼º È£»ê±¸¼º À°¾ÆÁ¾. Á¶Á÷±¸ÁõÀÇ ÀÏÁ¾À¸·Î °ñ ¼öÁú °øµ¿ ³»¿¡ Á¶Á÷±¸ÀÇ ÃàÀûÀÌ ´Ù¼Ò¼º º´¼Ò¸¦ Çü¼ºÇϰí ÀÌ ¶§ º´º¯¿¡ ³ªÅ¸³ª´Â Á¶Á÷±¸µéÀº ÈçÈ÷ Æ÷¸»¼º ¶Ç´Â °øÆ÷¼º ¼¼Æ÷ÁúÀ» °®´Â´Ù. 2. ´Ü¼Ò¼º È£»ê¼º À°¾ÆÁ¾ÀÇ 60% ÀÌ»óÀº µÎ°³°ñ, ´Á°ñ ¶Ç´Â ´ëÅð°ñÀ» ħ¹üÇϸç ÀÓ»ó °æ°ú´Â ¸Å¿ì ÁÁ°í ¼Ò¾Æ¿Í ÀþÀº ¿¬·ÉÃþ¿¡ ¸¹À¸¸ç ƯÈ÷ ³²ÀÚ¿¡¼­ ¹ß»ý ºóµµ°¡ ³ô´Ù. ´ÜÀϼº º´º¯Àº Áõ¼¼ ¾øÀÌ Á¸ÀçÇÏ´Â °æ¿ì°¡ ¸¹°í ¶§·Î´Â °ñ Á¶Á÷ÀÇ ¹Ì¶õ¼º º´º¯À¸·Î ÀÎÇÏ¿© ÅëÁõ ¶Ç´Â Åë°¢À» ´À³¢°í º´Àû °ñÀýÀ» À¯¹ßÇÒ ¼öµµ ÀÖ´Ù. 3. û¼Ò³â, ³²ÀÚ¿¡ ÈçÇÏ¸ç ¾Ç°ñ, ƯÈ÷ Ä¡¾Æ ÁÖÀ§ÀÇ Ä¡Á¶ µ¹±â¿¡ È£¹ßÇÑ´Ù. Åõ°ú¼º ¾Ï¿µÀÌ ºÒºÐ¸íÇÏ°Ô °æ°èµÇ¾î ÀÖ°í Ä¡¾Æ°¡ ¿¬Á¶Á÷¿¡ ¶° ÀÖ´Â ÀλóÀ» ÁØ´Ù. º´¼Ò´Â ´ë°³ Ä¡ÁÖ Áúȯ°ú ¼öÁ÷ÀûÀÎ Ä¡Á¶°ñ ¼Ò½ÇÀ» ¼ö¹ÝÇÑ´Ù. Ä¡ÁÖ¿°, Áֱ⼺ È£Áß±¸ °¨¼ÒÁõ, ¹éÇ÷º´ °ñ º´º¯ÀÌ ½ÉÇÏÁö ¾ÊÀ» ¶§ öÀúÇÑ ¼ÒÆÄ¼ú·Î Ä¡¾Æ¸¦ ±¸ÇØ¾ß ÇÑ´Ù.
  • eosinophilic inclusion body
    È£»ê±¸¼º ºÀÀÔü
  • eosinophilic leukemoid reaction
    È£»ê±¸¼º ¹éÇ÷º´¾ç ¹ÝÀÀ
  • eosinophilic leukocytosis
    È£»ê±¸¼º ¹éÇ÷±¸ Áõ°¡Áõ
  • eosinophilic meningoencephalitis
    È£»ê±¸¼º ³ú¸·¿°
  • eosinophilic panniculitis
    È£»ê±¸¼º Áö¹æÃþ¿°
  • eosinophilic pneumonia
    È£»ê±¸¼º Æó·Å
  • eosinophilic pulmonary syndrome
    È£»ê¼º Æó ÁõÈıº
    ¸¸¼º È£»ê±¸¼º Æó·ÅÀº ÆóÆ÷ ¼¼Ã´À̳ª »ý°Ë»ó È£»ê±¸°¡ Æó Á¶Á÷ÀÇ ¸»Ãʺο¡ Ä§ÂøµÈ ¼Ò°ßÀ» Ư¡À¸·Î ÇÏ´Â ÁõÈıºÀ» ÀǹÌÇÑ´Ù. Ç÷¾× È£»ê±¸ Áõ°¡°¡ ´ëºÎºÐ °üÂûµÈ´Ù. ¸¸¼º È£»ê±¸¼º Æó·ÅÀº ÁÖ·Î ¿©ÀÚ¿¡ ³ªÅ¸³ª¸ç, ¹ß¿­, ¹ßÇÑ, üÁß °¨¼Ò, È£Èí °ï¶õÀÌ Æ¯Â¡ÀÌ´Ù. Ä¡·á´Â °æ±¸
  • eosinophilic pustular folliculitis
    È£»ê±¸¼º ³óÆ÷¼º ¸ð³¶¿°
  • eosinophilic spongiosis
    È£»ê±¸¼º ÇØ¸éÈ­
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
receptors, granulocyte-colony-stimulating factor Receptors that bind and internalise granulocyte-colony-stimulating factor. Their mw is believed to be 150 kD. These receptors are found mainly on a subset of myelomonocytic cells.
(12 Dec 1998)
receptors, granulocyte-macrophage colony-stimulating factor Receptors that bind and internalise the granulocyte-macrophage stimulating factor. Their mw is believed to be 84 kD. The most mature myelomonocytic cells, specifically human neutrophils, macrophages, and eosinophils, express the highest number of affinity receptors for this growth factor.
(12 Dec 1998)
granulocyte <haematology> Leucocyte with conspicuous cytoplasmic granules. In humans the granulocytes are also classified as polymorphonuclear leucocytes and are subdivided according to the staining properties of the granules into eosinophils, basophils and neutrophils (using a Romanovsky type stain), some invertebrate blood cells are also referred to, not very helpfully, as granulocytes.
(12 Dec 1998)
granulocyte-colony-stimulating factor <growth factor, haematology, oncology> A glycoprotein of 25 kD containing internal disulfide bonds.
It induces the survival, proliferation, and differentiation of neutrophilic granulocyte precursor cells and functionally activates mature blood neutrophils. Among the family of colony-stimulating factors, G-CSF is the most potent inducer of terminal differentiation to granulocytes and macrophages of leukaemic myeloid cell lines.
A protein that stimulates the growth and maturation of granulocytes. It is used to promote the recovery of the white cells following chemotherapy.
See: colony-stimulating factor.
Acronym: G-CSF
(12 Dec 1998)
granulocyte-macrophage colony-stimulating factor <growth factor, haematology, oncology> An acidic glycoprotein of mw 23 kD with internal disulfide bonds.
It is produced in response to a number of inflammatory mediators by mesenchymal cells present in the haemopoietic environment and at peripheral sites of inflammation.
It stimulates the production of neutrophilic granulocytes, macrophages, and mixed granulocyte-macrophage colonies from bone marrow cells and can stimulate the formation of eosinophil colonies from foetal liver progenitor cells. It also has some functional activities in mature granulocytes and macrophages.
It is used to promote the recovery of the white blood cells following chemotherapy.
Chemical name: Colony-stimulating factor 2
See: colony-stimulating factor.
Acronym: GM-CSF
(12 Dec 1998)
immature granulocyte An immature neutrophil, except that it may be neutrophilic, acidophilic, or basophilic in character.
(05 Mar 2000)
parasitic eosinophilic lung disease <radiology> All are metazoans (mostly nematodes), Ascaris, Strongyloides, Ancyclostoma, Schistosoma, tropical pulmonary eosinophilia, pulmonary larva migrans
(12 Dec 1998)
chronic eosinophilic pneumonia <radiology> Idiopathic, associated with allergies and desensitization, variant of Loeffler pneumonia, treatment: corticosteroids Findings: reverse pulmonary oedema pattern (= Loeffler's), areas of consolidation persists (days to weeks) see: eosinophilic lung disease
(12 Dec 1998)
drug-induced eosinophilic lung disease <radiology> Diffuse reticular pattern: nitrofurantoin, Loeffler-like pattern: penicillin, sulfonamides, ASA, para-ASA, imipramine, HCTZ, cromolyn sodium see: eosinophilic lung disease
(12 Dec 1998)
eosinophilic Staining readily with eosin dyes; denoting such cell or tissue elements.
(05 Mar 2000)
eosinophilic cellulitis <syndrome> Recurrent cellulitis followed by brawny edematous skin lesions, or a less acute presentation of papular, annular, or gyrate skin lesions which are sometimes urticarial; affected skin and subcutis are heavily infiltrated by eosinophils and histiocytes, with scattered small necrotic foci (flame figures) of varied aetiology; sometimes follows an arthropod bite.
Synonym: eosinophilic cellulitis.
(05 Mar 2000)
eosinophilic cystitis Bladder inflammation with many eosinophils in urinary sediment as well as bladder wall.
(05 Mar 2000)
eosinophilic endomyocardial disease A restrictive cardiomyopathy associated with hyperproduction of eosinophiles and their cardiac infiltration, clinically characterised by diastolic and later systolic ventricular failure.
(05 Mar 2000)
eosinophilic fasciitis <pathology> A syndrome which is characterised by inflammation of the fascia and muscles of the extremities. Infiltrations of eosinophils are found in affected muscle tissue and fascia. The cause is unknown.
Symptoms include tenderness and swelling of arms and legs, joint contractures, bone apins, muscle aches and muscle weakness. Some may complain of carpal tunnel syndrome symptoms with numbness and tingling in the hands.
Diagnosis is made by tissue biopsy.
Treatment includes systemic corticosteroids. The illness can last for 3 to 5 years and then ususally resolves.
(27 Sep 1997)
eosinophilic gastritis <radiology> Eosinophilic infiltration of mucosa, submucosa, and muscularis of small bowel with or without stomach, stomach (almost always limited to antrum): enlarged gastric rugae, cobblestone nodules, polyps (=mucosal type), rigid wall with narrowed antrum/pylorus, bulky inramural mass up to 9 cm (=muscular type), wet stomach, ulcers rare, may have ascites, small bowel (predominantly jejunum), thickening and distortion of folds (=mucosal type), effacement of mucosa and narrowing of lumen (=muscular type), prognosis: tendency to spontaneous remission, treatment: steroids; removal of sensitizing agent
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • granulocyte
    °ú¸³¼º ¹éÇ÷±¸;°ú¸³±¸
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á